Profile data is unavailable for this security.
About the company
Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of novel tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. It operates through two divisions for its sales, marketing and research and development (R&D) activities, including Surgical and Woundcare. Its surgical business unit is focused on selling and marketing its branded products and are sold directly and through distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under their own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA.
- Revenue in GBP (TTM)126.21m
- Net income in GBP15.89m
- Incorporated1993
- Employees800.00
- LocationAdvanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
- Phone+44 160 686 3500
- Fax+44 160 686 3600
- Websitehttps://www.admedsol.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tristel Plc | 39.49m | 6.04m | 220.85m | 213.00 | 37.01 | 7.08 | 25.81 | 5.59 | 0.1256 | 0.1256 | 0.8219 | 0.6567 | 0.992 | 1.51 | 6.26 | 185,394.40 | 15.17 | 8.86 | 17.10 | 10.24 | 82.59 | 80.63 | 15.29 | 10.63 | 3.93 | 411.73 | 0.1605 | 109.99 | 15.70 | 10.14 | 351.98 | 6.40 | 9.88 | 18.05 |
| Nyxoah SA | 3.72m | -36.99m | 221.77m | 147.00 | -- | 2.64 | -- | 59.59 | -1.55 | -1.55 | 0.1555 | 3.42 | 0.0322 | 0.7891 | 2.06 | 29,618.53 | -31.98 | -23.73 | -35.88 | -25.98 | 61.91 | 62.42 | -993.86 | -1,469.59 | 4.50 | -- | 0.1147 | -- | 40.99 | -- | -38.39 | -- | 100.58 | -- |
| BICO Group AB | 164.96m | -124.41m | 228.00m | 884.00 | -- | 0.6508 | -- | 1.38 | -23.61 | -27.66 | 31.60 | 69.18 | 0.2487 | 2.24 | 3.06 | 2,545,136.00 | -18.77 | -- | -20.89 | -- | 52.34 | -- | -75.47 | -- | 1.91 | -1.05 | 0.2852 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
| Medistim ASA | 38.33m | 7.56m | 241.67m | 152.00 | 31.89 | 8.32 | 26.04 | 6.31 | 5.68 | 5.68 | 28.77 | 21.77 | 1.07 | 0.8646 | 5.98 | 3,462,921.00 | 21.01 | 22.93 | 26.14 | 28.52 | 78.67 | 78.25 | 19.72 | 20.64 | 2.61 | -- | 0.0425 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
| Lumibird SA | 174.23m | 6.10m | 268.25m | 1.05k | 39.20 | 1.62 | 12.81 | 1.54 | 0.3559 | 0.3559 | 9.14 | 8.62 | 0.5238 | 1.09 | 4.05 | 193,497.10 | 1.83 | 3.13 | 2.44 | 3.99 | 61.68 | 61.76 | 3.50 | 5.89 | 1.62 | 2.47 | 0.4287 | 0.00 | 6.60 | 15.12 | -37.23 | -2.47 | 18.34 | -- |
| COLTENE Holding AG | 213.95m | 10.53m | 280.20m | 1.20k | 26.58 | 3.28 | 16.91 | 1.31 | 2.00 | 2.00 | 40.62 | 16.21 | 1.33 | 1.40 | 6.58 | 201,937.60 | 6.53 | 10.48 | 10.90 | 18.74 | 64.24 | 62.68 | 4.92 | 7.47 | 0.8045 | 5.62 | 0.3172 | 79.94 | -9.13 | 3.54 | -54.05 | -6.81 | -7.72 | -7.79 |
| IVF Hartmann Holding AG | 130.41m | 13.35m | 289.81m | 304.00 | 21.71 | 2.17 | 15.91 | 2.22 | 6.31 | 6.31 | 61.63 | 63.07 | 0.8015 | 3.08 | 8.46 | 486,687.50 | 8.21 | 7.29 | 9.99 | 8.90 | 53.90 | 53.29 | 10.24 | 8.30 | 3.89 | -- | 0.0056 | 52.16 | -1.79 | 2.09 | 34.95 | 1.49 | -14.83 | 26.82 |
| Ion Beam Applications SA | 366.94m | -7.80m | 343.16m | 1.85k | -- | 3.63 | 166.29 | 0.9352 | -0.313 | -0.313 | 14.73 | 3.65 | 0.702 | 2.54 | 2.73 | -- | -1.49 | 1.55 | -5.92 | 4.32 | 31.36 | 35.23 | -2.12 | 2.38 | 0.7103 | 0.9417 | 0.2814 | 43.06 | 18.67 | 10.74 | -250.40 | -- | -8.06 | -- |
| Avon Protection PLC | 196.06m | -13.19m | 357.97m | 928.00 | -- | 2.86 | 101.17 | 1.83 | -0.4397 | -0.3861 | 6.54 | 4.13 | 0.7005 | 2.63 | 5.48 | 211,270.60 | -4.71 | -1.07 | -5.39 | -1.29 | 35.23 | 35.51 | -6.73 | -1.62 | 1.80 | 2.92 | 0.3822 | -- | -7.48 | 1.85 | -387.72 | -- | -1.66 | -7.86 |
| Safilo Group SpA | 877.07m | -21.10m | 381.77m | 3.83k | -- | 1.18 | 15.31 | 0.4353 | -0.0596 | -0.0596 | 2.48 | 0.9165 | 1.13 | 1.80 | 4.91 | 267,693.80 | -2.87 | -7.06 | -4.47 | -11.30 | 57.16 | 52.70 | -2.55 | -6.87 | 1.10 | 1.94 | 0.2848 | -- | -4.83 | 2.39 | -145.51 | -- | -15.50 | -- |
| CellaVision AB | 49.66m | 9.55m | 384.73m | 228.00 | 40.27 | 7.32 | 30.85 | 7.75 | 5.46 | 5.46 | 28.40 | 30.04 | 0.7441 | 1.60 | 6.93 | 2,970,575.00 | 14.32 | 15.30 | 16.62 | 18.24 | 68.37 | 69.03 | 19.24 | 19.98 | 2.01 | 59.03 | 0.0828 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
| Advanced Medical Solutions Group plc | 126.21m | 15.89m | 400.78m | 800.00 | 25.46 | 1.64 | 15.02 | 3.18 | 0.0724 | 0.0724 | 0.5755 | 1.12 | 0.4426 | 1.75 | 5.34 | -- | 5.57 | 6.54 | 6.04 | 7.06 | 55.57 | 56.75 | 12.59 | 14.82 | 4.00 | -- | 0.0361 | 25.83 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Stratec SE | 224.17m | 11.18m | 416.76m | 1.52k | 37.26 | 2.09 | 15.83 | 1.86 | 1.07 | 1.07 | 21.54 | 19.19 | 0.6062 | 1.51 | 4.45 | 172,083.40 | 3.02 | 7.07 | 3.69 | 8.20 | 24.76 | 27.32 | 4.99 | 9.70 | 1.09 | 5.38 | 0.394 | 40.81 | -4.63 | 6.88 | -55.29 | 3.30 | -2.16 | -7.68 |
| medmix AG | 428.90m | 264.43k | 544.09m | 2.66k | 1,493.01 | 1.31 | 11.02 | 1.27 | 0.01 | 0.01 | 11.91 | 11.41 | 0.4606 | 3.65 | 6.05 | 183,070.00 | 0.0663 | 2.06 | 0.0846 | 2.49 | 32.41 | 36.38 | 0.1439 | 4.16 | 1.23 | 2.92 | 0.4244 | 67.70 | 1.99 | 1.40 | -97.41 | -64.36 | 12.01 | -- |
| Revenio Group Oyj | 82.75m | 16.27m | 561.78m | 216.00 | 34.14 | 6.55 | 28.59 | 6.79 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| Synsam AB (publ) | 432.95m | 22.80m | 585.09m | 3.41k | 25.49 | 3.14 | 7.56 | 1.35 | 2.09 | 2.09 | 39.62 | 16.96 | 0.7356 | 2.22 | 13.12 | 1,730,149.00 | 3.86 | -- | 5.27 | -- | 75.50 | -- | 5.25 | -- | 0.4922 | -- | 0.5675 | -- | 11.90 | -- | -5.18 | -- | -- | -- |
Data as of Apr 19 2024. Currency figures normalised to Advanced Medical Solutions Group PLC's reporting currency: UK Pound GBX
47.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 03 Apr 2024 | 28.28m | 13.01% |
| Canaccord Genuity Wealth Ltd.as of 29 Dec 2023 | 16.60m | 7.64% |
| Investec Wealth & Investment Ltd.as of 29 Dec 2023 | 12.69m | 5.84% |
| Charles Stanley & Co. Ltd.as of 29 Dec 2023 | 11.32m | 5.21% |
| Invesco Asset Management Ltd.as of 29 Dec 2023 | 8.57m | 3.94% |
| Rathbones Investment Management Ltd.as of 21 Sep 2023 | 7.17m | 3.30% |
| AXA Investment Managers UK Ltd.as of 29 Dec 2023 | 6.85m | 3.15% |
| Evelyn Partners Investment Management LLPas of 01 Feb 2024 | 4.02m | 1.85% |
| BlackRock Fund Advisorsas of 01 Feb 2024 | 3.94m | 1.81% |
| Royal London Asset Management Ltd.as of 01 Feb 2024 | 3.78m | 1.74% |
More ▼
Data from 31 Dec 2023 - 29 Mar 2024Source: FactSet Research Systems Inc.
